67 related articles for article (PubMed ID: 29392689)
21. NK cells recognize and kill human glioblastoma cells with stem cell-like properties.
Castriconi R; Daga A; Dondero A; Zona G; Poliani PL; Melotti A; Griffero F; Marubbi D; Spaziante R; Bellora F; Moretta L; Moretta A; Corte G; Bottino C
J Immunol; 2009 Mar; 182(6):3530-9. PubMed ID: 19265131
[TBL] [Abstract][Full Text] [Related]
22. Primary glioblastoma cultures: can profiling of stem cell markers predict radiotherapy sensitivity?
Lemke D; Weiler M; Blaes J; Wiestler B; Jestaedt L; Klein AC; Löw S; Eisele G; Radlwimmer B; Capper D; Schmieder K; Mittelbronn M; Combs SE; Bendszus M; Weller M; Platten M; Wick W
J Neurochem; 2014 Oct; 131(2):251-64. PubMed ID: 24976529
[TBL] [Abstract][Full Text] [Related]
23. The emerging role of tumor-suppressive microRNA-218 in targeting glioblastoma stemness.
Gao X; Jin W
Cancer Lett; 2014 Oct; 353(1):25-31. PubMed ID: 25042866
[TBL] [Abstract][Full Text] [Related]
24. TGFβ-Responsive HMOX1 Expression Is Associated with Stemness and Invasion in Glioblastoma Multiforme.
Ghosh D; Ulasov IV; Chen L; Harkins LE; Wallenborg K; Hothi P; Rostad S; Hood L; Cobbs CS
Stem Cells; 2016 Sep; 34(9):2276-89. PubMed ID: 27354342
[TBL] [Abstract][Full Text] [Related]
25. Melatonin inhibits tumorigenicity of glioblastoma stem-like cells via the AKT-EZH2-STAT3 signaling axis.
Chen X; Hao A; Li X; Du Z; Li H; Wang H; Yang H; Fang Z
J Pineal Res; 2016 Sep; 61(2):208-17. PubMed ID: 27121240
[TBL] [Abstract][Full Text] [Related]
26. STAT3 is essential for the maintenance of neurosphere-initiating tumor cells in patients with glioblastomas: a potential for targeted therapy?
Villalva C; Martin-Lannerée S; Cortes U; Dkhissi F; Wager M; Le Corf A; Tourani JM; Dusanter-Fourt I; Turhan AG; Karayan-Tapon L
Int J Cancer; 2011 Feb; 128(4):826-38. PubMed ID: 20473906
[TBL] [Abstract][Full Text] [Related]
27. Enhancement of SOX-2 expression and ROS accumulation by culture of A172 glioblastoma cells under non-adherent culture conditions.
Im CN; Yun HH; Yoo HJ; Park MJ; Lee JH
Oncol Rep; 2015 Aug; 34(2):920-8. PubMed ID: 26035068
[TBL] [Abstract][Full Text] [Related]
28. miR128-1 inhibits the growth of glioblastoma multiforme and glioma stem-like cells via targeting BMI1 and E2F3.
Shan ZN; Tian R; Zhang M; Gui ZH; Wu J; Ding M; Zhou XF; He J
Oncotarget; 2016 Nov; 7(48):78813-78826. PubMed ID: 27705931
[TBL] [Abstract][Full Text] [Related]
29. [A novel adherent culture method of glioblastoma cells expressing CD133 using collagen-1-coated plates].
Motegi H; Kamoshima Y; Terasaka S; Kobayashi H; Houkin K
Hokkaido Igaku Zasshi; 2012 Aug; 87(4-5):147-51. PubMed ID: 23016266
[TBL] [Abstract][Full Text] [Related]
30. Glioblastoma and stem cells.
Altaner C
Neoplasma; 2008; 55(5):369-74. PubMed ID: 18665745
[TBL] [Abstract][Full Text] [Related]
31. Paired related homeobox 1 transactivates dopamine D2 receptor to maintain propagation and tumorigenicity of glioma-initiating cells.
Li Y; Wang W; Wang F; Wu Q; Li W; Zhong X; Tian K; Zeng T; Gao L; Liu Y; Li S; Jiang X; Du G; Zhou Y
J Mol Cell Biol; 2017 Aug; 9(4):302-314. PubMed ID: 28486630
[TBL] [Abstract][Full Text] [Related]
32. Differential role of EGF and BFGF in human GBM-TIC proliferation: relationship to EGFR-tyrosine kinase inhibitor sensibility.
Bajetto A; Porcile C; Pattarozzi A; Scotti L; Aceto A; Daga A; Barbieri F; Florio T
J Biol Regul Homeost Agents; 2013; 27(1):143-54. PubMed ID: 23489694
[TBL] [Abstract][Full Text] [Related]
33. SOX2 silencing in glioblastoma tumor-initiating cells causes stop of proliferation and loss of tumorigenicity.
Gangemi RM; Griffero F; Marubbi D; Perera M; Capra MC; Malatesta P; Ravetti GL; Zona GL; Daga A; Corte G
Stem Cells; 2009 Jan; 27(1):40-8. PubMed ID: 18948646
[TBL] [Abstract][Full Text] [Related]
34. Glioblastoma stem-like cell lines with either maintenance or loss of high-level EGFR amplification, generated via modulation of ligand concentration.
Schulte A; Günther HS; Martens T; Zapf S; Riethdorf S; Wülfing C; Stoupiec M; Westphal M; Lamszus K
Clin Cancer Res; 2012 Apr; 18(7):1901-13. PubMed ID: 22316604
[TBL] [Abstract][Full Text] [Related]
35. Endothelial cells induce cancer stem cell features in differentiated glioblastoma cells via bFGF.
Fessler E; Borovski T; Medema JP
Mol Cancer; 2015 Aug; 14():157. PubMed ID: 26282129
[TBL] [Abstract][Full Text] [Related]
36. Targeting ROR1 inhibits the self-renewal and invasive ability of glioblastoma stem cells.
Jung EH; Lee HN; Han GY; Kim MJ; Kim CW
Cell Biochem Funct; 2016 Apr; 34(3):149-57. PubMed ID: 26923195
[TBL] [Abstract][Full Text] [Related]
37. Autocrine factors sustain glioblastoma stem cell self-renewal.
Li G; Chen Z; Hu YD; Wei H; Li D; Ji H; Wang DL
Oncol Rep; 2009 Feb; 21(2):419-24. PubMed ID: 19148517
[TBL] [Abstract][Full Text] [Related]
38. Crosstalk between the PI3K/mTOR and MEK/ERK pathways involved in the maintenance of self-renewal and tumorigenicity of glioblastoma stem-like cells.
Sunayama J; Matsuda K; Sato A; Tachibana K; Suzuki K; Narita Y; Shibui S; Sakurada K; Kayama T; Tomiyama A; Kitanaka C
Stem Cells; 2010 Nov; 28(11):1930-9. PubMed ID: 20857497
[TBL] [Abstract][Full Text] [Related]
39. A cell-autonomous positive-signaling circuit associated with the PDGF-NO-ID4-regulatory axis in glioblastoma cells.
Eun K; Jeon HM; Kim SO; Choi SH; Lee SY; Jin X; Kim SC; Kim H
Biochem Biophys Res Commun; 2017 Apr; 486(2):564-570. PubMed ID: 28327358
[TBL] [Abstract][Full Text] [Related]
40. Aberrant self-renewal and quiescence contribute to the aggressiveness of glioblastoma.
Campos B; Gal Z; Baader A; Schneider T; Sliwinski C; Gassel K; Bageritz J; Grabe N; von Deimling A; Beckhove P; Mogler C; Goidts V; Unterberg A; Eckstein V; Herold-Mende C
J Pathol; 2014 Sep; 234(1):23-33. PubMed ID: 24756862
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]